8030-76-0

8030-76-0 structure

Name: Soybean Lecithin
Chemical Name: 2-(Methyl{2-[4-(2-methylbenzyl)-1-piperazinyl]-2-oxoethyl}amino)-N-[2-(trifluoromethyl)phenyl]acetamide
CAS Number: 8030-76-0
Molecular Formula: C₂₄H₂₉F₃N₄O₂
Molecular Weight: 462.508
Catalog: Research Areas Others
Create Date: 2018-10-17 13:28:58
Modify Date: 2024-01-03 11:38:14
Soya Lecithin can be used as an excipient. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs[1].

Name	2-(Methyl{2-[4-(2-methylbenzyl)-1-piperazinyl]-2-oxoethyl}amino)-N-[2-(trifluoromethyl)phenyl]acetamide
Synonyms	2-(Methyl{2-[4-(2-methylbenzyl)-1-piperazinyl]-2-oxoethyl}amino)-N-[2-(trifluormethyl)phenyl]acetamid 2-(Methyl{2-[4-(2-methylbenzyl)-1-piperazinyl]-2-oxoethyl}amino)-N-[2-(trifluoromethyl)phenyl]acetamide Acetamide, 2-[methyl[2-[4-[(2-methylphenyl)methyl]-1-piperazinyl]-2-oxoethyl]amino]-N-[2-(trifluoromethyl)phenyl]- Soybean Lecithin

Description	Soya Lecithin can be used as an excipient. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs[1].
Related Catalog	Research Areas >> Others Signaling Pathways >> Others >> Others
References	[1]. Elder DP, et al. Pharmaceutical excipients - quality, regulatory and biopharmaceutical considerations. Eur J Pharm Sci. 2016 May 25;87:88-99.